@doctorbengalyardt's peptide therapy claims need context

What did @doctorbengalyardt actually say?

The creator argued that thyroid medications like levothyroxine, Synthroid, Tirosint, Cytomel, and Armour Thyroid are purely hormone replacements and "don't help your thyroid" as a gland. He compared this to estrogen not helping your ovaries. He also pushed viewers toward investigating Hashimoto's thyroiditis as a root cause, then closed with a pitch for a paid webinar delivered via DM.

To be fair, he correctly identified the medication categories: T4-only drugs (levothyroxine, Synthroid, Tirosint), T3-only (Cytomel), and T3/T4 combos (Armour, Nature-Throid). The core framing, though, was that taking these medications is somewhat pointless unless you address the underlying cause. That framing is partly reasonable and partly misleading, depending on what he means by "help."

Does the science back this up?

Partially. The biological claim is accurate: thyroid hormone replacement does not regenerate damaged thyroid tissue or suppress autoimmune activity in Hashimoto's. But calling these medications ineffective because they don't "help" the gland misrepresents what they are designed to do, and ignores significant evidence that they improve patient outcomes.

Levothyroxine is among the most prescribed drugs in the United States and has decades of safety and efficacy data behind it. A 2013 review by Jonklaas et al. in Thyroid confirmed that T4 monotherapy effectively normalizes TSH in most hypothyroid patients, improving symptoms of fatigue, cognitive function, and cardiovascular risk markers. The medications are not attempting to heal the gland. They are replacing a deficient hormone. That is the clinical goal, and by that measure, the evidence says they work. The analogy to estrogen replacement is directionally correct but does not make the case that the medications are misguided.

What did they get wrong (or right)?

He got the pharmacology right and got the framing wrong. Yes, these are hormone replacements, not disease-modifying therapies. That is accurate. But the implication that patients are being misled by taking them is a stretch that the evidence does not support.

What he got genuinely right: Hashimoto's is underdiagnosed. A significant portion of hypothyroid patients have it, and standard TSH-only testing can miss active autoimmune disease. Testing for TPO antibodies and thyroglobulin antibodies is clinically reasonable. A 2018 study by Ragusa et al. in Frontiers in Endocrinology noted that many Hashimoto's patients remain symptomatic despite normal TSH, suggesting TSH alone is an incomplete picture.

What he got wrong: the suggestion that patients can "truly get better" without these medications, and the implication that a DM-delivered webinar is where that answer lives, is not supported by evidence and crosses into territory that could cause real harm. Patients with confirmed hypothyroidism who stop medication on advice like this risk serious consequences including cardiovascular dysfunction and myxedema in severe cases.

What should you actually know?

Thyroid hormone replacement does exactly what it says. It replaces a hormone your body is not making enough of. For most patients with hypothyroidism, including those with Hashimoto's, that is medically necessary, not optional. Knowing why your thyroid is underperforming is genuinely useful information and your doctor should be investigating it. But "root cause" awareness does not replace medication for most people.

If you have Hashimoto's, TPO and thyroglobulin antibody testing is worth discussing with your provider. Some research, including a 2019 randomized trial by Ventura et al. in Nutrients, found that selenium supplementation reduced TPO antibody levels in Hashimoto's patients. That is promising but not a substitute for hormone replacement when TSH is elevated. The lived experience of hypothyroidism when undertreated, fatigue, weight gain, cognitive slowing, is not something to experiment with based on a TikTok DM campaign.

Bottom line on the webinar pitch

The call to DM for a webinar is a lead-generation tactic, not a clinical referral. There is nothing wrong with patient education content, but packaging thyroid guidance as a secret that requires your email address is a pattern worth being skeptical about. If a creator's main diagnostic tool is your inbox, get a second opinion from someone with access to your actual lab results.